News

January 24, 2013

Companion Diagnostics, Key to Development of Personalized Medicines, Face Hurdles

BOSTON — Jan. 24, 2013 — Companion diagnostics, which are central to the creation of personalized medicines, have captured the interest of many drug companies, but face a number of hurdles that could impede development, according to a panel of leaders from the research-based drug industry recently convened by the Tufts Center for the Study of Drug Development. Still mostly in the early stages of development, companion diagnostics—tests linked to a therapeutic medicine that help identify a population of patients who are likely to respond to the drug
ABOUT RESEARCH COURSES & FORUMS LIBRARY & BIBLIOGRAPHY REPORTS SPONSORED RESEARCH NEWS